Results 111 to 120 of about 708,583 (274)

Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis

open access: yesJAMA Neurology, 2019
Key Points Question Is dabigatran etexilate or dose-adjusted warfarin efficacious and safe to use in preventing the recurrence of venous thrombotic events among patients with cerebral venous thrombosis? Findings In this exploratory randomized, open-label
J. Ferro   +14 more
semanticscholar   +1 more source

Development and validation of a predictive model for chemotherapy-associated thrombosis.

open access: yesBlood, 2008
Risk of venous thromboembolism (VTE) is elevated in cancer, but individual risk factors cannot identify a sufficiently high-risk group of outpatients for thromboprophylaxis.
A. Khorana   +4 more
semanticscholar   +1 more source

MESENTERIC THROMBOSIS [PDF]

open access: green, 1920
GEORGE G. ROSS
openalex   +1 more source

Contribution a la modelisation et simulation numerique de l ecoulement du sang dans l artere [PDF]

open access: yesarXiv, 2009
Numerous are the questionings raised by medicine interventionnelle, concerning the hold in charge of the pathologies of the arterial partition (aneurysm, dissection, coarctation, atherosclerosis).for it we made the modeling and the numeric simulation of the blood flow in the renal artery taken by the Medical imagery.
arxiv  

Primary Human Lung Alveolus‐on‐a‐chip Model of Intravascular Thrombosis for Assessment of Therapeutics

open access: yesClinical pharmacology and therapy, 2018
Pulmonary thrombosis is a significant cause of patient mortality; however, there are no effective in vitro models of thrombi formation in human lung microvessels that could also assess therapeutics and toxicology of antithrombotic drugs.
Abhishek Jain   +12 more
semanticscholar   +1 more source

Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A

open access: yesHaematologica, 2013
The activity of the factor VIII coagulation protein can be measured by three methods: a one or two-stage clotting assay and a chromogenic assay. The factor VIII activity of most individuals with mild hemophilia A is the same regardless of which method is
Annette E. Bowyer   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy